Evidence map›Paper›PMID 33123074›Full record

ArticleFrontiers in neurology2020

BV-2 Microglial Cells Overexpressing

Hannah Rostalski, Tomi Hietanen, Stina Leskelä, Andrea Behánová, Ali Abdollahzadeh, Rebekka Wittrahm, Petra Mäkinen, Nadine Huber, Dorit Hoffmann, Eino Solje and 6 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Moderate intrinsic phenotypic alterations inFrontiers in cellular neuroscience · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hannah RostalskiA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Tomi HietanenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Stina LeskeläA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Andrea BehánováA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Ali AbdollahzadehA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Rebekka WittrahmInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Petra MäkinenInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Nadine HuberA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Dorit HoffmannA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Eino SoljeInstitute of Clinical Medicine-Neurology, University of Eastern Finland, Kuopio, Finland.
Anne M RemesUnit of Clinical Neuroscience, Neurology, University of Oulu, Oulu, Finland.
Teemu NatunenInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Mari TakaloInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Jussi TohkaA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Mikko HiltunenInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Annakaisa HaapasaloA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hexanucleotide repeat expansion (HRE) in the

Indexed as

amyotrophic lateral sclerosisBV-2 cellsC9orf72 DPRsC9orf72 hexanucleotide repeat expansionfrontotemporal lobar degenerationmicroglianeuroinflammationTDP-43

Identifiers

PMID33123074
PMCPMC7573144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.